Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Howland

Showing results (51-60 of 192) with videos related to

Pageof 20
Sort By:
Journal of Psychosocial Nursing and Mental Health Services|August 15, 2009
Understanding chirality and stereochemistry: three-dimensional psychopharmacologyRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|October 20, 2009
Effects of aging on pharmacokinetic and pharmacodynamic drug processesRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|February 20, 2010
When is a "generic" medication not really a generic?Robert H Howland
Journal of Psychosocial Nursing and Mental Health Services|November 22, 2005
Atypical antipsychotics: special formulations for acute agitationRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|March 10, 2010
Are generic medications safe and effective?Robert H Howland
Journal of Psychosocial Nursing and Mental Health Services|October 1, 2008
Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 1: study designRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|July 4, 2008
Understanding the placebo effect. Part 2: underlying psychological & neurobiological processesRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|April 10, 2015
Brexpiprazole: another multipurpose antipsychotic drug?Robert H Howland
Journal of Psychosocial Nursing and Mental Health Services|August 7, 2013
Antidepressant drugs and infectious diseaseRobert H Howland
Drug Safety|August 12, 2011
A benefit-risk assessment of agomelatine in the treatment of major depressionRobert H Howland
Pageof 20

Showing results (51-60 of 192) with videos related to

Sort By:
Pageof 20
Journal of Psychosocial Nursing and Mental Health Services|August 15, 2009
Understanding chirality and stereochemistry: three-dimensional psychopharmacologyRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|October 20, 2009
Effects of aging on pharmacokinetic and pharmacodynamic drug processesRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|February 20, 2010
When is a "generic" medication not really a generic?Robert H Howland
Journal of Psychosocial Nursing and Mental Health Services|November 22, 2005
Atypical antipsychotics: special formulations for acute agitationRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|March 10, 2010
Are generic medications safe and effective?Robert H Howland
Journal of Psychosocial Nursing and Mental Health Services|October 1, 2008
Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 1: study designRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|July 4, 2008
Understanding the placebo effect. Part 2: underlying psychological & neurobiological processesRobert H Howland
Journal of Psychosocial Nursing and Mental Health Services|April 10, 2015
Brexpiprazole: another multipurpose antipsychotic drug?Robert H Howland
Journal of Psychosocial Nursing and Mental Health Services|August 7, 2013
Antidepressant drugs and infectious diseaseRobert H Howland
Drug Safety|August 12, 2011
A benefit-risk assessment of agomelatine in the treatment of major depressionRobert H Howland
Pageof 20